Richard Nolan Townsend - Net Worth and Insider Trading
Richard Nolan Townsend Net Worth
The estimated net worth of Richard Nolan Townsend is at least $818,312 dollars as of 2024-12-28. Richard Nolan Townsend is the CEO of Lexeo Therapeutics Inc and owns about 120,695 shares of Lexeo Therapeutics Inc (LXEO) stock worth over $818,312. Details can be seen in Richard Nolan Townsend's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard Nolan Townsend has not made any transactions after 2024-12-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard Nolan Townsend
Richard Nolan Townsend Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard Nolan Townsend owns 1 companies in total, including Lexeo Therapeutics Inc (LXEO) .
Click here to see the complete history of Richard Nolan Townsend’s form 4 insider trades.
Insider Ownership Summary of Richard Nolan Townsend
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
LXEO | Lexeo Therapeutics Inc | 2024-12-10 | director & Chief Executive Officer |
Richard Nolan Townsend Latest Holdings Summary
Richard Nolan Townsend currently owns a total of 1 stock. Richard Nolan Townsend owns 120,695 shares of Lexeo Therapeutics Inc (LXEO) as of December 10, 2024, with a value of $818,312.
Latest Holdings of Richard Nolan Townsend
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
LXEO | Lexeo Therapeutics Inc | 2024-12-10 | 120,695 | 6.78 | 818,312 |
Holding Weightings of Richard Nolan Townsend
Richard Nolan Townsend Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard Nolan Townsend has made a total of 8 transactions in Lexeo Therapeutics Inc (LXEO) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Lexeo Therapeutics Inc is the sale of 2,500 shares on December 10, 2024, which brought Richard Nolan Townsend around $20,500.
Insider Trading History of Richard Nolan Townsend
- 1
Richard Nolan Townsend Trading Performance
Richard Nolan Townsend Ownership Network
Richard Nolan Townsend Owned Company Details
What does Lexeo Therapeutics Inc do?
Who are the key executives at Lexeo Therapeutics Inc?
Richard Nolan Townsend is the director & Chief Executive Officer of Lexeo Therapeutics Inc. Other key executives at Lexeo Therapeutics Inc include 10 percent owner Lundbeckfond Invest A/s , 10 percent owner Omega Fund Vi Gp, L.p. , and 10 percent owner Longitude Capital Partners Iv, Llc .
Lexeo Therapeutics Inc (LXEO) Insider Trades Summary
Over the past 18 months, Richard Nolan Townsend made 8 insider transaction in Lexeo Therapeutics Inc (LXEO) with a net sale of 85,000. Other recent insider transactions involving Lexeo Therapeutics Inc (LXEO) include a net purchase of 454,545 shares made by Omega Fund Vi Gp, L.p. , a net purchase of 454,545 shares made by Longitude Capital Partners Iv, Llc , and a net purchase of 227,272 shares made by Lundbeckfond Invest A/s .
In summary, during the past 3 months, insiders sold 10,000 shares of Lexeo Therapeutics Inc (LXEO) in total and bought 15,000 shares, with a net purchase of 5,000 shares. During the past 18 months, 85,000 shares of Lexeo Therapeutics Inc (LXEO) were sold and 1,151,362 shares were bought by its insiders, resulting in a net purchase of 1,066,362 shares.
Lexeo Therapeutics Inc (LXEO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lexeo Therapeutics Inc Insider Transactions
Richard Nolan Townsend Mailing Address
Above is the net worth, insider trading, and ownership report for Richard Nolan Townsend. You might contact Richard Nolan Townsend via mailing address: C/o Lexeo Therapeutics, Inc., 345 Park Avenue South, 6th Floor, New York Ny 10010.